|
1
|
Wyllie AH: Apoptosis (the 1992 Frank Rose
Memorial Lecture). Br J Cancer. 67:205–208. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Favaloro B, Allocati N, Graziano V, et al:
Role of apoptosis in disease. Aging (Albany NY). 4:330–349.
2012.
|
|
3
|
Jellinger KA: The enigma of vascular
cognitive disorder and vascular dementia. Acta Neuropathol.
113:349–388. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ni J, Ohta H, Matsumoto K and Watanabe H:
Progressive cognitive impairment following chronic cerebral
hypoperfusion induced by permanent occlusion of bilateral carotid
arteries in rats. Brain Res. 653:231–236. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim SK, Cho KO and Kim SY: White matter
damage and hippocampal neurodegeneration induced by permanent
bilateral occlusion of common carotid artery in the rat: Comparison
between Wistar and Sprague-Dawley strain. Korean J Physiol
Pharmacol. 12:89–94. 2008. View Article : Google Scholar
|
|
6
|
Cechetti F, Worm PV, Pereira LO, et al:
The modified 2VO ischemia protocol causes cognitive impairment
similar to that induced by the standard method, but with a better
survival rate. Braz J Med Biol Res. 43:1178–1183. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gong X, Ma M, Fan X, et al:
Down-regulation of IGF-1/IGF-1R in hippocampus of rats with
vascular dementia. Neurosci Lett. 513:20–24. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Takaoka M: Resveratrol, a new phenolic
compound from Veratrum grandiflorum. Nippon Kagaku Kaishi.
60:1090e1001939.
|
|
9
|
Shen M, Wu RX, Zhao L, et al: Resveratrol
attenuates ischemia/reperfusion injury in neonatal cardiomyocytes
and its underlying mechanism. PLoS One. 7:e512232012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ku CR, Lee HJ, Kim SK, et al: Resveratrol
prevents streptozotocin-induced diabetes by inhibiting the
apoptosis of pancreatic β-cell and the cleavage of poly
(ADP-ribose) polymerase. Endocr J. 59:103–109. 2012.PubMed/NCBI
|
|
11
|
Robb EL, Page MM, Wiens BE and Stuart JA:
Molecular mechanisms of oxidative stress resistance induced by
resveratrol: Specific and progressive induction of MnSOD. Biochem
Biophys Res Commun. 367:406–412. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bo S, Ciccone G, Castiglione A, et al:
Anti-inflammatory and antioxidant effects of resveratrol in healthy
smokers a randomized, double-blind, placebo-controlled, cross-over
trial. Curr Med Chem. 20:1323–1331. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Athar M, Back JH, Kopelovich L, et al:
Multiple molecular targets of resveratrol: Anti-carcinogenic
mechanisms. Arch Biochem Biophys. 486:95–102. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Simão F, Matté A, Breier AC, et al:
Resveratrol prevents global cerebral ischemia-induced decrease in
lipid content. Neurol Res. 35:59–64. 2013.PubMed/NCBI
|
|
15
|
Li Z, Pang L, Fang F, et al: Resveratrol
attenuates brain damage in a rat model of focal cerebral ischemia
via up-regulation of hippocampal Bcl-2. Brain Res. 1450:116–124.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu Z, Xu Q, Zhang L, et al: Protective
effect of resveratrol against kainate-induced temporal lobe
epilepsy in rats. Neurochem Res. 34:1393–1400. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pasinetti GM, Wang J, Marambaud P, et al:
Neuroprotective and metabolic effects of resveratrol: therapeutic
implications for Huntington’s disease and other neurodegenerative
disorders. Exp Neurol. 232:1–6. 2011.PubMed/NCBI
|
|
18
|
Khan MM, Ahmad A, Ishrat T, et al:
Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage
and dopamine depletion in rat model of Parkinson’s disease. Brain
Res. 1328:139–151. 2010.PubMed/NCBI
|
|
19
|
Li F, Gong Q, Dong H and Shi J:
Resveratrol, a neuroprotective supplement for Alzheimer’s disease.
Curr Pharm Des. 18:27–33. 2012.
|
|
20
|
Guidance suggestions for the care and use
of laboratory animals. The Ministry of Science and Technology of
the People’s Republic of China; Beijing: 2006
|
|
21
|
Ma XR, Sun ZK, Liu YR, et al: Resveratrol
improves cognition and reduces oxidative stress in rats with
vascular dementia. Neural Regen Res. 8:2050–2059. 2013.PubMed/NCBI
|
|
22
|
Sun ZK, Yang HQ, Pan J, et al: Protective
effects of erythropoietin on tau phosphorylation induced by
beta-amyloid. J Neurosci Res. 86:3018–3027. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Levine DA and Langa KM: Vascular cognitive
impairment: disease mechanisms and therapeutic implications.
Neurotherapeutics. 8:361–373. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bennett S, Grant MM and Aldred S:
Oxidative stress in vascular dementia and Alzheimer’s disease: a
common pathology. J Alzheimers Dis. 17:245–257. 2009.
|
|
25
|
Wang J, Zhang HY and Tang XC: Cholinergic
deficiency involved in vascular dementia: possible mechanism and
strategy of treatment. Acta Pharmacol Sin. 30:879–888. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gustafsson AB and Gottlieb RA: Bcl-2
family members and apoptosis, taken to heart. Am J Physiol Cell
Physiol. 292:C45–C51. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wolter KG, Hsu YT, Smith CL, et al:
Movement of Bax from the cytosol to mitochondria during apoptosis.
J Cell Biol. 139:1281–1292. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Clementi ME, Pezzotti M, Orsini F, et al:
Alzheimer’s amyloid beta-peptide (1-42) induces cell death in human
neuroblastoma via bax/bcl-2 ratio increase: an intriguing role for
methionine 35. Biochem Biophys Res Commun. 342:206–213. 2006.
|
|
29
|
Sun ZK, Yang HQ, Wang ZQ, et al:
Erythropoietin prevents PC12 cells from beta-amyloid-induced
apoptosis via PI3K/Akt pathway. Transl Neurodegener. 1:72012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Grütter MG: Caspases: key players in
programmed cell death. Curr Opin Struct Biol. 10:649–655. 2000.
|
|
31
|
Lee MK, Kang SJ, Poncz M, et al:
Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis
induced by dopamine. Exp Mol Med. 39:376–384. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Alvarez-Gonzalez R, Spring H, Müller M and
Bürkle A: Selective loss of poly(ADP-ribose) and the 85-kDa
fragment of poly(ADP-ribose) polymerase in nucleoli during
alkylation-induced apoptosis of HeLa cells. J Biol Chem.
274:32122–32126. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee DH, Park T and Kim HW: Induction of
apoptosis by disturbing mitochondrial-membrane potential and
cleaving PARP in Jurkat T cells through treatment with
acetoxyscirpenol mycotoxins. Biol Pharm Bull. 29:648–654. 2006.
View Article : Google Scholar
|
|
34
|
Oliver FJ, de la Rubia G, Rolli V, et al:
Importance of poly(ADP-ribose) polymerase and its cleavage in
apoptosis. Lesson from an uncleavable mutant. J Biol Chem.
273:33533–33539. 1998. View Article : Google Scholar : PubMed/NCBI
|
